13F filing recap · Q1 2009

What did Bill & Melinda Gates Foundation Trust buy in Q1 2009?

Reported stock-position changes between this filing and the previous one.

Stock value

$8.48B

Positions

Estimated turnover

6.9%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

XLVTechnology Select Sector SPDR Fund$354.80Mreported value+14.65M shares ALTHAllos Therapeutics Inc$3.09Mreported value+500.0K shares VRTXVertex Pharmaceuticals Inc / Ma$2.73Mreported value+95.0K shares XNPTXenoport, Inc.$2.52Mreported value+130.0K shares MYLPrAMylan N.v.$2.23Mreported value+2.6K shares RDEAArdea Biosciences Inc$2.17Mreported value+210.4K shares AUXLAuxilium Pharmaceuticals Inc$2.06Mreported value+74.4K shares AMAGAmag Pharmaceuticals Inc$1.84Mreported value+50.0K shares ITMNIntermune Inc$1.81Mreported value+109.9K shares ARYXAryx Therapeutics Inc$1.64Mreported value+480.8K shares BMRNBiomarin Pharmaceutical Inc$1.29Mreported value+104.9K shares INCYIncyte Corporation$1.02Mreported value+435.7K shares CMEDChina Medical Technologies Inc$996.0Kreported value+72.3K shares VRUSPharmasset Inc$821.0Kreported value+83.6K shares REGNRegeneron Pharmaceuticals, Inc.$492.0Kreported value+35.5K shares MAPPMap Pharmaceuticals Inc$98.0Kreported value+46.5K shares ETRMEnteromedics Inc$81.0Kreported value+59.7K shares OREXOrexigen Therapeutics Inc$36.0Kreported value+13.9K shares

Increased positions

CATCaterpillar Inc$212.22Mreported value+2.50M shares+49.1%ABTAbbott Laboratories$169.08Mreported value+74.5K shares+2.1%ANAutonation, Inc.$142.85Mreported value+50.0K shares+0.5%BAXBaxter International Inc$104.63Mreported value+42.8K shares

Reduced positions

BRK.BBerkshire Hathaway Inc$3.67Breported value-50.0K shares-3.7%